The pathogenesis of osteonecrosis is associated with the Negative effects from the antiangiogenic mechanisms of those drugs, resulting in a disrupted blood stream. Our review aims to look at the latest insights into osteonecrosis activated by new anti-cancer drugs. Most reports focus on the osteonecrosis with the jaw (ONJ); even so, we identified t